Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02-Reference-Cited by-同舟云学术

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02

Published:1995-02 Issue:3 Volume:31 Page:453-459
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Murray Kevin J.,Nelson Diana F.,Scott Charles,Fischbach A.Jennifer,Porter Arthur,Farnan Nancy,Curran Walter J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference14 articles.

1. Subjective measures of well being;Campbel;Am. Pyschol.,1976

2. Population-based norms for the minimal-mental state examination by age and educational level;Crum;JAMA,1993

3. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant gliomas: A preliminary report of the Radiation Therapy Oncology Group 8302;Curran;Cancer,1992

4. A new endpoint for the assessment of adjuvant therapy in postmenopausal woman with operable breast cancer;Gelber;J. Clin. Oncol.,1986

5. Costs and benefits of adjuvant therapy in breast cancer: A quality adjusted survival analysis;Goldhirsch;J. Clin. Oncol.,1989

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy;Journal of Clinical Medicine;2022-10-10

2. Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities;Journal of Neuro-Oncology;2019-06-12

3. Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial;Journal of Neuro-Oncology;2019-05-04

4. Late Radiation Outcomes of Patients with Newly Diagnosed Glioblastoma Treated with Accelerated Hyperfractionated Radiotherapy and Temozolomide;Turkish Journal of Oncology;2019

5. Post-Treatment Neurocognitive Disorders in Adults with Frontal or Parietal Astrocytomas;Reports of Radiotherapy and Oncology;2016-03-31